2-181677112-A-AT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The NM_002500.5(NEUROD1):​c.*677dupA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.078 ( 872 hom., cov: 0)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NEUROD1
NM_002500.5 3_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.959

Publications

1 publications found
Variant links:
Genes affected
NEUROD1 (HGNC:7762): (neuronal differentiation 1) This gene encodes a member of the NeuroD family of basic helix-loop-helix (bHLH) transcription factors. The protein forms heterodimers with other bHLH proteins and activates transcription of genes that contain a specific DNA sequence known as the E-box. It regulates expression of the insulin gene, and mutations in this gene result in type II diabetes mellitus. [provided by RefSeq, Jul 2008]
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]
CERKL Gene-Disease associations (from GenCC):
  • CERKL-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 26
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0878 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEUROD1NM_002500.5 linkc.*677dupA 3_prime_UTR_variant Exon 2 of 2 ENST00000295108.4 NP_002491.3 Q13562A0A0S2Z493
NEUROD1NR_146175.2 linkn.88+3317dupA intron_variant Intron 1 of 1
NEUROD1NR_146176.2 linkn.88+3317dupA intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEUROD1ENST00000295108.4 linkc.*677dupA 3_prime_UTR_variant Exon 2 of 2 1 NM_002500.5 ENSP00000295108.3 Q13562

Frequencies

GnomAD3 genomes
AF:
0.0785
AC:
3854
AN:
49082
Hom.:
872
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0563
Gnomad AMI
AF:
0.0457
Gnomad AMR
AF:
0.0566
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.0852
Gnomad SAS
AF:
0.0653
Gnomad FIN
AF:
0.0250
Gnomad MID
AF:
0.125
Gnomad NFE
AF:
0.0908
Gnomad OTH
AF:
0.0557
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
80
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
50
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
78
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
0.00
AC:
0
AN:
2
GnomAD4 genome
AF:
0.0784
AC:
3852
AN:
49104
Hom.:
872
Cov.:
0
AF XY:
0.0758
AC XY:
1625
AN XY:
21434
show subpopulations
African (AFR)
AF:
0.0563
AC:
773
AN:
13742
American (AMR)
AF:
0.0565
AC:
161
AN:
2850
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
215
AN:
1518
East Asian (EAS)
AF:
0.0847
AC:
145
AN:
1712
South Asian (SAS)
AF:
0.0645
AC:
79
AN:
1224
European-Finnish (FIN)
AF:
0.0250
AC:
12
AN:
480
Middle Eastern (MID)
AF:
0.118
AC:
4
AN:
34
European-Non Finnish (NFE)
AF:
0.0908
AC:
2413
AN:
26578
Other (OTH)
AF:
0.0556
AC:
33
AN:
594
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Maturity onset diabetes mellitus in young Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.96
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374172497; hg19: chr2-182541839; API